IP Library Granted Patent US 12685762
Granted Patent B2
US 12685762 · App. 17/772,908 · Granted Jul 21, 2026

Aqueous pharmaceutical composition containing fusion protein of serum albumin and growth hormone

Inventors: Shinji Okabe (Kobe, JP); Yuka Yamaguchi (Kobe, JP); Hidehito Yasukawa (Kobe, JP)
Assignee: JCR Pharmaceuticals Co., Ltd.
A61K38/385A61K9/08A61K38/27A61K47/26
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12685762
App. No.
17/772,908
Granted
Jul 21, 2026
Kind
B2
Abstract

An aqueous pharmaceutical composition containing 10-100 mg/mL of a fusion protein of human serum albumin and human growth hormone, 10-150 mg/mL of sucrose, 0.15-10 mg/mL of a nonionic surfactant, 0.5-12 mg/mL of a preservative, and 1-30 mM of a buffer is, and the pH of the composition is 5.0-8.0.

Claims (12)

1 . An aqueous pharmaceutical composition, comprising:

a fusion protein of human serum albumin and human growth hormone as an active ingredient at a concentration of 50 mg/mL;

sucrose at a concentration of 75 mg/mL;

a nonionic surfactant at a concentration of 3 mg/mL;

an antiseptic agent at a concentration of 6 mg/mL; and

a buffering agent at a concentration of 10 mM,

wherein a pH is 7.0 to 7.4,

wherein

the nonionic surfactant is polyoxyethylene (160) polyoxypropylene (30) glycol,

the antiseptic agent is phenol,

the buffering agent is a phosphate buffering agent, and

the fusion protein has the amino acid sequence of SEQ ID NO:11.